Nori Health starts ADJUVANT, a clinical study to investigate the impact of its digital therapy app on digestive disease patients

Nori Health, a digital healthcare startup focused on inflammatory diseases, announced today that the first patients have started the pilot phase of ADJUVANT, a clinical trial of the digital therapy program in the Nori Health app. The study is being conducted in The Netherlands in collaboration with THINC (The Healthcare Innovation Center, UMC Utrecht) at the Elisabeth-TweeSteden Hospital (ETZ) in Tilburg and the Radboudumc hospital in Nijmegen.

The research focuses specifically on people living with chronic intestinal disorders, Crohn’s disease or ulcerative colitis. Previous studies show that the quality of life for bowel patients is lower when compared to healthy individuals and that many patients can take a more active role in self-management of their condition to improve this. Self-management can not only provide health benefits for patients, but also lead to lower healthcare costs.

Read more on Medtechdive: